| Literature DB >> 32395282 |
Prasad S Adusumilli1,2, Marom Bikson3, Nabil P Rizk1, Valerie W Rusch1, Boris Hristov1, Rachel Grosser1, Kay See Tan4, Inderpal S Sarkaria1, James Huang1, Daniela Molena1, David R Jones1, Manjit S Bains1.
Abstract
BACKGROUND: Anastomotic leak following Ivor Lewis esophagectomy is associated with increased morbidity/mortality and decreased survival. Tissue oxygenation at the anastomotic site may influence anastomotic leak. Methods for establishing tissue oxygenation at the anastomotic site are lacking.Entities:
Keywords: Esophageal cancer; anastomotic leak; tissue oxygenation; tissue perfusion
Year: 2020 PMID: 32395282 PMCID: PMC7212129 DOI: 10.21037/jtd.2020.02.58
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Publications on tissue oxygenation measurement
| Article | N | Year | TiO2 evaluation | Type of surgery | Tissue oxygenation measurement—objective (O) or subjective (S) | Registered clinical trial | Primary outcome | Conclusions |
|---|---|---|---|---|---|---|---|---|
| Schilling | 11 | 1996 | US doppler | Esophagectomies | S | No | US Doppler blood flux | Blood flux decreases as gastric conduit is created |
| Jacobi | 33 | 1997 | Polarographic oxygen electrode | Esophagectomies | O | No | TiO2 of leak | No difference was noted in TiO2 between the two groups |
| Karliczek | 77 | 2009 | Visible light spectroscopy | Colorectal | O | No | TiO2 of leak | Lack of rise in TiO2 after creation of anastomosis is associated with increased leaks |
| Gareau | 22 | 2010 | Optical fiber spectroscopy | Esophagectomies | O | No | Median TiO2, BVF and all anastomotic complications | Low TiO2 at the last two stages of esophagectomy correlate with increased leaks |
| Pham | 23 | 2011 | Optical fiber spectroscopy | Esophagectomies | O | No | TiO2, BVF and all anastomotic complications | Large drop in TiO2 during conduit creation corresponded to leaks |
| Campbell | 90 | 2015 | Indocyanine dye + US doppler | Esophagectomies | S | No | Leak rates before and after protocol implementation | Noted a decrease in leak rate after implementation of protocol |
| Adusumilli | 114 | 2016 | Reflectance pulse oximetry | Esophagectomies | O | Yes | TiO2 of leak | No difference was noted in TiO2 between the two groups |
Comparison of current oximeter options
| Oximeter design | Benefits | Limitations |
|---|---|---|
| Electrochemical sensor | Noninvasive | Requires local vasodilation |
| Can be applied intraoperatively | High electrical resistivity | |
| Moderate sensitivity | Poor accuracy | |
| Needs frequent calibration | ||
| Reflectance electro-optical plethysmography probe | Intraoperative oxygen monitoring | Requires dark room calibration |
| Disposable sensor cover | High motion sensitivity | |
| Accurate measurements | Large prove size | |
| Intrapartum pulse oximeter probe | Noninvasive | Large probe |
| Signal processing executed away so less power and device bulk needed | Reduced sensitivity depending on location | |
| Measures systemic oxygen | ||
| Hybrid reflectance pulse oximeter | Continuous fetal blood oxygen saturation monitoring | Requires precalibration |
| Intrauterine device used to guide sensor | Reduced reading accuracy at local points of interest | |
| Reflectance esophageal pulse oximeter probe | Blood gas analysis & co-oximetry used as gold standards for measuring oxygen against esophageal values | Device not tested in region of low pH, where gastric acidity may affect measurements |
| Intraoperative oral pulse oximeter sensor | Higher accuracy when compared to peripheral oximeter readings in burn patients | Measure systemic oxygen |
| Specific conditions required for readings >85% | ||
| Contact period determines oxygen readings | ||
| WiPOX | Noninvasive, intraoperative sensor | Requires sterilization for multiple uses |
| Compact and economic design | Battery operated | |
| Reliable readings (accuracy ±4%) | ||
| Measures O2 saturation locally throughout the anastomosis (>45 minutes) | ||
| Multiple application points |
Figure 1Wireless Pulse Oximetry (WiPOX) device (A) optimized for measurement of gastric conduit tissue oxygenation intra-operatively. The tissue contact sensors measure the tissue oxygenation and display the number along with simultaneous measurement of the heart rate along with the pulsatile oxygenation wave form for measurement reliability (B).
Patient characteristics
| Characteristic | All patients (n=114) | No leak group (n=106) | Leak group (n=8) |
|---|---|---|---|
| Age | |||
| ≤65 | 67 (58.8) | 62 (58.5) | 5 (62.5) |
| >65 | 47 (41.2) | 44 (41.5) | 3 (37.5) |
| Sex | |||
| F | 17 (14.9) | 16 (15.1) | 1 (12.5) |
| M | 97 (85.1) | 90 (84.9) | 7 (87.5) |
| Smoking history | |||
| Never | 35 (30.7) | 32 (30.2) | 3 (37.5) |
| Former | 76 (66.7) | 71 (67.0) | 5 (62.5) |
| Current | 3 (2.6) | 3 (2.8) | 0 (0.0) |
| Pathologic stage | |||
| 0 | 22 (19.3) | 21 (19.8) | 1 (12.5) |
| 1 | 33 (28.9) | 29 (27.4) | 4 (50.0) |
| 2 | 32 (28.1) | 31 (29.2) | 1 (12.5) |
| 3 | 25 (21.9) | 23 (21.7) | 2 (25.0) |
| Benign pathology | 2 (1.7) | 2 (1.9) | 0 (0.0) |
| Neo-adjuvant therapy | |||
| No chemo | 24 (21.1) | 21 (19.8) | 3 (37.5) |
| ChemoRT | 86 (75.4) | 82 (77.4) | 4 (50.0) |
| Chemo only | 4 (3.5) | 3 (2.8) | 1 (12.5) |
| Comorbidity | |||
| HTN | 54 (47.4) | 49 (46.2) | 5 (62.5) |
| CAD | 13 (11.4) | 10 (9.4) | 3 (37.5) |
| Arrhythmia | 4 (3.5) | 4 (3.8) | 0 (0.0) |
| COPD | 6 (5.3) | 5 (4.7) | 1 (12.5) |
| DM | 10 (8.8) | 10 (9.4) | 0 (0.0) |
Data are No. (%). CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; Chemo, chemotherapy; chemoRT, chemoradiotherapy; DM, diabetes mellitus; HTN, hypertension.
Figure 2Median tissue oxygenation values in patients with and without anastomotic leak shown as a box plot.
Figure 3Anastomotic leak rates in study participants and non-participants (A) and the severity of anastomotic leaks graded according to standard Common Terminology Criteria for Adverse Events (CTCAE) v4.0 criteria in study participants and non-participants (B).
Figure 4Systemic oxygenation does not reflect gastric conduit tissue oxygenation (A). There are no differences in gastric conduit tissue oxygenation among patients who received induction chemotherapy and those who did not (B). There are no differences in gastric conduit tissue oxygenation among patients who received induction radiation therapy and those who did not (C).